NHS

A £330M Palantir contract is under UK review as NHS coverage shifts from pandemic technology toward scrutiny of data infrastructure, cyber resilience and vendor dependence.

Who they are

The NHS is the UK’s publicly funded health service and appears in coverage as a major deployer and steward of health technology: from clinical AI and patient-data platforms to hospital supply services and digital public-health systems. Its scale makes it a consequential customer for technology companies and a focal point for debates over medical-data governance and critical-service security.

The recent arc

Recent coverage has moved from a 2023Q4 high point into a more intermittent but sharper focus on the governance of NHS technology. The latest stories, in June 2026, concern lawmakers’ calls to end the £330M Palantir deal and the UK’s full review of that contract, bringing dependence on a US technology supplier to the foreground. A 2025 report on Foresight, trained on anonymized data from 57M people in England, likewise placed large-scale health data at the center of the story.

The preceding phase was defined by operational vulnerability and applied care technology. The June 2024 ransomware attack on pathology provider Synnovis disrupted London hospitals, followed by Qilin’s publication of nearly 400GB of sensitive data that the NHS investigated. In parallel, coverage documented deployment of Eko AI stethoscopes in 200 GP surgeries, AI sensors intended to reduce readmissions, and a Zipline partnership for medical-supply deliveries. Earlier peak coverage in 2020 centered on NHSX’s COVID-19 contact-tracing work with Google and Apple and the NHS’s choice of a centralized approach.

The tension

The persistent tension is between extracting operational and clinical value from data-driven systems and retaining public control, privacy and resilience. That tension has recurred from Google DeepMind’s NHS data-sharing controversy and the Apple-Google contact-tracing debate to Palantir’s federated-data role, while the Synnovis incident showed that healthcare dependence on digital and service suppliers can turn a cyberattack into disruption of frontline care.

Why it matters

If the current trajectory holds, NHS technology choices will remain a test case for how a national health system can use AI, integrated data and external platforms without weakening patient trust or critical-service resilience. The Palantir review may clarify the acceptable role of major foreign vendors, while cyber incidents and new UK protections for public services suggest that procurement, data governance and supplier security will increasingly be treated as inseparable questions.

Related: Palantir · Google · Apple · COVID-19 · Several London hospitals face major disruptions after a June 3 ransomw